The Journal of Targeted Oncology Research (JTOR) is an international, open-access, peer-reviewed journal devoted to advancing innovation in cancer research and targeted therapeutic strategies.

Aims:

• To promote cutting-edge research in the biology, diagnosis, treatment, and prevention of cancer.
• To highlight the development and clinical application of targeted therapies, including small molecules, monoclonal antibodies, immunotherapies, and gene-based treatments.
• To bridge the gap between laboratory discoveries and clinical practice by supporting translational and clinical oncology research.
• To foster interdisciplinary collaboration across oncology, pharmacology, molecular biology, genetics, immunology, and related fields.
• To disseminate evidence-based practices and innovative therapeutic approaches that advance personalized and precision cancer medicine.

Scope:
JTOR welcomes original research articles, comprehensive reviews, short communications, and case reports covering, but not limited to, the following areas:

• Biomarkers for cancer diagnosis, prognosis, and treatment response.
• Development of novel targeted agents and advanced drug delivery systems.
• Clinical trials and real-world studies evaluating targeted therapies.
• Cancer genomics, epigenetics, and proteomics.
• Tumor microenvironment and immuno-oncology.
• Mechanisms of resistance to targeted treatments.
• Precision medicine and personalized therapeutic strategies.
• Combination therapies involving targeted drugs, chemotherapy, and radiation.
• Preclinical and translational oncology research bridging bench to bedside.

By providing a global platform for high-quality scientific exchange, the Journal of Targeted Oncology Research (JTOR) aims to advance the understanding of cancer biology and contribute to the development of more effective, targeted, and individualized treatment options for patients worldwide.

Key Areas of Focus

• Cancer Biology & Genetics.
• Cancer Prevention.
• Diagnostic Advances.
• Treatment Modalities.
• Personalized & Precision Medicine.
• Supportive & Palliative Care.
• Clinical Trials & Translational Research.
• Global Cancer Burden.
• Future Directions.